When was last look?: Large variety of insulins. New guidelines. Relaxation of targets for some. Glp-1 agonists. First sodium glucose co-transporter 2 inhibitor, Invokana (canaglifozin) , approved just recently. Despite all the new, fundamentals remain.... Diet exercise, wt loss. Medications as necessary to achieve targets. Control BP and ldl.
Answered 6/26/2014
5.2k views
6 doctors weighed in across 4 answers
A doctor has provided 1 answer
3 doctors weighed in across 3 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question